Arch Biopartners Hires d3 Medicine to Develop a Human Trial for Brain Tumor …

Arch Biopartners Hires d3 Medicine to Develop a Human Trial for Brain Tumor …

Arch intends to perform this human trial to characterize the safety and pharmacokinetics of MetaMx and to demonstrate the efficacy of MetaMx to cross the human blood brain barrier and detect brain tumor initiating cells (BTICs) and invasive glioma cells.

(Visited 1 times, 1 visits today)
18
Like
Save

Comments

Comments are disabled for this post.